[ESC/EAS Guidelines for the management of dyslipidaemias]

Rev Esp Cardiol. 2011 Dec;64(12):1168.e1-1168.e60. doi: 10.1016/j.recesp.2011.09.014.
[Article in Spanish]
No abstract available

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Algorithms
  • Cardiovascular Diseases / prevention & control
  • Dyslipidemias / drug therapy
  • Dyslipidemias / economics
  • Dyslipidemias / therapy*
  • Goals
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Lipids / blood
  • Risk Assessment
  • Spain

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
  • Lipids